In this commentary reviewing the activity of the University of Geneva islet transplantation program, the author argues that health care coverage of the procedure will stop discrimination against a subset of patients with type 1 diabetes in need of beta-cell replacement but unfit to receive a whole pancreas transplant.
To cite this article
Not reimbursing islet transplantation creates discrimination against patients with type 1 diabetes
Submission date: 01 Oct 2019
Revised on: 11 Oct 2019
Accepted on: 29 Oct 2019
Published online: 31 Oct 2019
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.